Skip to main content Skip to footer
American Family Children's Hospital
SHARE TEXT
 


Print Friendly Page

Protocol No. NRGGI004

Principal Investigator Mulkerin, Daniel

Phase III

Age Group Adult

Scope National

Sponsor Type National

Title Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or Without Atezolizumab or Atezolizumab

Applicable Disease Sites Colon and Rectum

Drugs Involved 5-fu (5-fluorouracil); Atezolizumab; Avastin (bevacizumab); Eloxatin (oxaliplatin); Eloxatina (oxaliplatin); L-OHP (oxaliplatin); MPDL3280A (Atezolizumab); SR 96669 (oxaliplatin); bevacizumab; leucovorin; leukovorin (leucovorin); lv (leucovorin); oxaliplatin; rhu Mab VEGF (bevacizumab); wellcovorin (leucovorin)

Status Open (affiliates only)

Participating Institutions Aspirus UW Cancer Center (formerly Riverview Hospital); Aspirus Wausau Hospital, Aspirus Regional Cancer Center; Langlade Memorial Hospital, Aspirus Regional Cancer Ctr; Mercy Health Systems, Janesville